Actor Irrfan Khan, who is currently undergoing treatment for neuroendocrine tumour in London, might be back in India after Diwali.
There were reports that Irrfan will start working on "Hindi Medium 2" as soon he is in India.
His spokesperson on Wednesday released a statement denying such speculations, and sharing an update about his visit to the country.
"The story floating about Irrfan starting 'Hindi Medium 2' shoot in December are all based on speculations. However there is a possibility of him returning to India after Diwali," Irrfan's spokesperson said.
Back in March, Irrfan had revealed that he has been diagnosed with rare tumour.
"The unexpected makes us grow, which is what the past few days have been about. Learning that I have been diagnosed with neuroendocrine tumour as of now has admittedly been difficult, but the love and strength of those around me and that I found within me has brought me to a place of hope," he had expressed.
In June, Irrfan penned a heartfelt letter about how life-changing the disease has been for him, and how it has made him realise "how you are just a cork floating in the ocean with unpredictable currents".
A National Award winner, Irrfan has stood out for his performance in films like "Paan Singh Tomar", "Talvar", "Maqbool", "7 Khoon Maaf", "Piku" and "Hindi Medium".
In the West, he has starred in films like "The Namesake", "Life of Pi", "A Mighty Heart", "Slumdog Millionaire", "The Amazing Spider-Man" and "Inferno".
--IANS
sug/nv/sed
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
